This site is intended for health professionals only

Thursday 20 June 2019

Beth Kennedy

Articles by this author

Fri 15 March
Fri 15 March
Research led by the Royal College of Surgeons in Ireland (RCSI) has been awarded €7m to investigate new treatments for Parkinson’s over three years.
Mon 25 February
Mon 25 February
Deleting a specific gene in mice alleviates arthritis symptoms and could be used to formulate a cure in humans, researchers have found.
Wed 23 January
Wed 23 January
Those aged 18-29 are the most likely to suffer an asthma attack and least likely to receive life-saving asthma care than any other age group, research has revealed.
Mon 21 January
Mon 21 January
The National Institute of health and Care Excellence (NICE) has recommended Verzenios (abemaciclib) in combination with an aromatase inhibitor (AI) to treat metastatic breast cancer
Tue 8 January
Tue 8 January
New plans for the NHS to tackle ‘killer conditions’ such as strokes and heart attacks could save up to half a million lives, the UK’s Government has announced.
Tue 13 November
Tue 13 November
Excess fat causes the body’s cancer-fighting “natural killer cells” to fail, explaining the link between obesity and cancer, researchers have said.
Thu 30 August
Thu 30 August
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ratio of daunorubicin and cytarabine
Mon 6 August
Mon 6 August
New patient groups with cancer-associated venous thromboembolism (VTE) could benefit from taking once-daily oral LIXIANA (edoxaban), a recent analysis has said.
Mon 2 July
Mon 2 July
The CHMP has given a positive opinion recommending Novartis’s Kymriah (tisagenlecleucel) to treat two aggressive blood cancers.
Wed 20 June
Wed 20 June
Manufacturer Amgen has received approval from the European Commission (EC) to include overall survival (OS) data on the labels of the drug BLINCYTO (blinatumomab), it has announced.